Pharmacodynamics of immunosuppressive drugs
Open Access
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 12 (5) , 557-562
- https://doi.org/10.1016/s0952-7915(00)00138-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1Transplantation, 1999
- Newer Immunosuppressive DrugsJournal of the American Society of Nephrology, 1999
- Therapeutic drug monitoring of immunosuppressant drugsBritish Journal of Clinical Pharmacology, 1999
- The Monitoring of Immunosuppressive Drugs: A Pharmacodynamic ApproachTherapeutic Drug Monitoring, 1998
- Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomideCurrent Opinion in Immunology, 1996
- CYCLOSPORINE INHIBITION OF LEUKOCYTE CALCINEURIN IS MUCH LESS IN WHOLE BLOOD THAN IN CULTURE MEDIUMTransplantation, 1996
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulationCytokine, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Whole-blood lymphocyte culturesJournal of Immunological Methods, 1989